VC-backed Turnstone Biologics buys Myst Therapeutics
Ottawa-based biotechnology company Turnstone Biologics has acquired Myst Therapeutics, a Los Angeles-based developer of novel T-cell therapies for solid tumors.
Ottawa-based biotechnology company Turnstone Biologics has acquired Myst Therapeutics, a Los Angeles-based developer of novel T-cell therapies for solid tumors.
Copyright PEI Media
Not for publication, email or dissemination